New York State Common Retirement Fund’s Vertex Pharmaceuticals VRTX Stock Holding History

New York State Common Retirement Fund’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$138M	Sell	277,614 -14,800	-5%	-$6.56M	0.17%	94
2026 Q1	$131M	Sell	292,414 -5,000	-2%	-$2.33M	0.18%	99
2025 Q4	$135M	Sell	297,414 -11,163	-4%	-$4.81M	0.18%	102
2025 Q3	$121M	Sell	308,577 -31,695	-9%	-$13.2M	0.16%	116
2025 Q2	$151M	Sell	340,272 -5,524	-2%	-$2.55M	0.2%	95
2025 Q1	$168M	Sell	345,796 -16,538	-5%	-$7.71M	0.25%	82
2024 Q4	$146M	Buy	362,334 +2,855	+0.8%	+$1.32M	0.2%	90
2024 Q3	$167M	Sell	359,479 -29,073	-7%	-$14M	0.23%	82
2024 Q2	$182M	Sell	388,552 -3,304	-0.8%	-$1.43M	0.24%	75
2024 Q1	$164M	Sell	391,856 -17,170	-4%	-$7.26M	0.22%	89
2023 Q4	$166M	Sell	409,026 -32,708	-7%	-$12.1M	0.23%	83
2023 Q3	$154M	Sell	441,734 -27,459	-6%	-$9.6M	0.22%	93
2023 Q2	$165M	Buy	469,193 +7,379	+2%	+$2.49M	0.21%	99
2023 Q1	$146M	Sell	461,814 -10,904	-2%	-$3.27M	0.2%	103
2022 Q4	$137M	Buy	472,718 +2,228	+0.5%	+$679K	0.19%	107
2022 Q3	$136M	Sell	470,490 -20,242	-4%	-$5.82M	0.2%	100
2022 Q2	$138M	Buy	490,732 +4,322	+0.9%	+$1.16M	0.18%	113
2022 Q1	$127M	Sell	486,410 -3,438	-0.7%	-$816K	0.14%	145
2021 Q4	$108M	Sell	489,848 -13,535	-3%	-$2.63M	0.11%	168
2021 Q3	$91.3M	Buy	503,383 +6,248	+1%	+$1.22M	0.1%	189
2021 Q2	$100M	Buy	497,135 +5,588	+1%	+$1.17M	0.1%	179
2021 Q1	$106M	Sell	491,547 -20,053	-4%	-$4.4M	0.12%	156
2020 Q4	$121M	Sell	511,600 -27,800	-5%	-$6.38M	0.13%	149
2020 Q3	$147M	Sell	539,400 -26,130	-5%	-$7.21M	0.18%	112
2020 Q2	$164M	Sell	565,530 -3,725	-0.7%	-$1.01M	0.21%	95
2020 Q1	$135M	Sell	569,255 -1,120	-0.2%	-$257K	0.2%	98
2019 Q4	$125M	Sell	570,375 -11,200	-2%	-$2.27M	0.15%	135
2019 Q3	$98.5M	Buy	581,575 +5,000	+0.9%	+$885K	0.12%	165
2019 Q2	$106M	Sell	576,575 -83,005	-13%	-$14.5M	0.13%	149
2019 Q1	$121M	Sell	659,580 -52,900	-7%	-$9.77M	0.16%	126
2018 Q4	$118M	Sell	712,480 -44,900	-6%	-$7.78M	0.17%	121
2018 Q3	$146M	Sell	757,380 -19,700	-3%	-$3.51M	0.17%	115
2018 Q2	$132M	Sell	777,080 -20,900	-3%	-$3.24M	0.16%	121
2018 Q1	$130M	Sell	797,980 -42,351	-5%	-$6.92M	0.16%	123
2017 Q4	$126M	Buy	840,331 +17,800	+2%	+$2.64M	0.15%	139
2017 Q3	$125M	Buy	822,531 +27,484	+3%	+$4.14M	0.16%	133
2017 Q2	$102M	Buy	795,047 +43,846	+6%	+$5.28M	0.14%	155
2017 Q1	$82.1M	Sell	751,201 -12,099	-2%	-$1.07M	0.11%	186
2016 Q4	$56.2M	Buy	763,300 +3,600	+0.5%	+$293K	0.08%	239
2016 Q3	$66.3M	Buy	759,700 +2,300	+0.3%	+$217K	0.1%	207
2016 Q2	$65.2M	Buy	757,400 +59,700	+9%	+$5.16M	0.1%	211
2016 Q1	$55.5M	Buy	697,700 +67,900	+11%	+$6.14M	0.08%	236
2015 Q4	$79.2M	Sell	629,800 -22,000	-3%	-$2.66M	0.12%	163
2015 Q3	$67.9M	Buy	651,800 +3,235	+0.5%	+$416K	0.11%	184
2015 Q2	$80.1M	Sell	648,565 -9,310	-1%	-$1.17M	0.12%	168
2015 Q1	$77.6M	Buy	657,875 +3,475	+0.5%	+$416K	0.11%	192
2014 Q4	$77.7M	Sell	654,400 -43,639	-6%	-$4.91M	0.12%	184
2014 Q3	$78.4M	Sell	698,039 -17,386	-2%	-$1.66M	0.12%	180
2014 Q2	$67.7M	Sell	715,425 -22,000	-3%	-$1.54M	0.1%	213
2014 Q1	$52.2M	Hold	737,425	–	–	0.08%	263
2013 Q4	$54.8M	Sell	737,425 -96,300	-12%	-$6.71M	0.09%	232
2013 Q3	$63.2M	Buy	833,725 +133,200	+19%	+$10.6M	0.11%	192
2013 Q2	$56M	Buy	+700,525	New	+$51.6M	0.1%	216

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

New York State Common Retirement Fund's VRTX Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Vertex Pharmaceuticals (VRTX) stake by 5.1% in Q2 2026, selling an estimated $6.56M and leaving 277,614 shares worth $138M. The position accounts for 0.17% of the portfolio, ranked #94.

New York State Common Retirement Fund first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $182M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

New York State Common Retirement Fund held 277,614 shares of Vertex Pharmaceuticals worth $138M as of Q2 2026.
New York State Common Retirement Fund sold 14,800 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.56M.
Vertex Pharmaceuticals made up 0.17% of New York State Common Retirement Fund's portfolio in Q2 2026, its #94 holding.
New York State Common Retirement Fund first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
New York State Common Retirement Fund's Vertex Pharmaceuticals position peaked at $182M in Q2 2024.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.